Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-30 4:29 pm Purchase |
2025-04-28 | 13D | Jade Biosciences, Inc. JBIO |
Atlas Venture Fund XII, L.P. | 51,406 0.200% |
51,406 (New Position) |
Filing History |
| 2022-12-15 4:06 pm Sale |
2022-12-12 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 58,264 8.300% |
-8,691 (-12.98%) |
Filing History |
| 2022-07-20 4:22 pm Sale |
2022-07-15 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 66,955 9.600% |
-8,691 (-11.49%) |
Filing History |
| 2022-05-05 4:04 pm Purchase |
2022-04-01 | 13D | Aerovate Therapeutics, Inc. AVTE |
Atlas Venture Fund XII, L.P. | 75,646 10.800% |
75,646 (New Position) |
Filing History |
| 2022-01-21 4:39 pm Purchase |
2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL |
Atlas Venture Fund XII, L.P. | 4,808,896 17.000% |
4,808,896 (New Position) |
Filing History |